Pathogenesis-oriented therapy of psoriasis using biologics
WH Boehncke, NC Brembilla - Expert Opinion on Biological …, 2022 - Taylor & Francis
Introduction Psoriasis is currently regarded an immune-mediated inflammatory disease. The
central pathogenic axis comprises interleukin-23, TH17-lymphocytes differentiating under its …
central pathogenic axis comprises interleukin-23, TH17-lymphocytes differentiating under its …
Pathogenesis-oriented therapy of psoriasis using biologics.
WH Boehncke, NC Brembilla - Expert Opinion on Biological …, 2022 - europepmc.org
Psoriasis is currently regarded an immune-mediated inflammatory disease. The central
pathogenic axis comprises interleukin-23, TH17-lymphocytes differentiating under its …
pathogenic axis comprises interleukin-23, TH17-lymphocytes differentiating under its …
Pathogenesis-oriented therapy of psoriasis using biologics
WH Boehncke, NC Brembilla - Expert opinion on …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Psoriasis is currently regarded an immune-mediated inflammatory disease. The
central pathogenic axis comprises interleukin-23, TH17-lymphocytes differentiating under its …
central pathogenic axis comprises interleukin-23, TH17-lymphocytes differentiating under its …